| Symbol |
Name |
|
AASDH
|
aminoadipate-semialdehyde dehydrogenase
|
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABI1
|
abl-interactor 1
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACER2
|
alkaline ceramidase 2
|
|
ACO1
|
aconitase 1, soluble
|
|
ACPP
|
acid phosphatase, prostate
|
|
ACVR1
|
activin A receptor, type I
|
|
ADAM10
|
ADAM metallopeptidase domain 10
|
|
ADAM15
|
ADAM metallopeptidase domain 15
|
|
ADAP1
|
ArfGAP with dual PH domains 1
|
|
ADCYAP1
|
adenylate cyclase activating polypeptide 1 (pituitary)
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADIPOR1
|
adiponectin receptor 1
|
|
ADIPOR2
|
adiponectin receptor 2
|
|
ADM
|
adrenomedullin
|
|
ADORA1
|
adenosine A1 receptor
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADORA2B
|
adenosine A2b receptor
|
|
ADORA3
|
adenosine A3 receptor
|
|
ADRM1
|
adhesion regulating molecule 1
|
|
AFP
|
alpha-fetoprotein
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR2
|
angiotensin II receptor, type 2
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AIF1
|
allograft inflammatory factor 1
|
|
AIM2
|
absent in melanoma 2
|
|
AIMP1
|
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1
|
|
AIP
|
aryl hydrocarbon receptor interacting protein
|
|
AKR1B1
|
aldo-keto reductase family 1, member B1 (aldose reductase)
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
ALOX5AP
|
arachidonate 5-lipoxygenase-activating protein
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ANGPT4
|
angiopoietin 4
|
|
ANGPTL2
|
angiopoietin-like 2
|
|
ANXA1
|
annexin A1
|
|
ANXA2
|
annexin A2
|
|
ANXA2R
|
annexin A2 receptor
|
|
APAF1
|
apoptotic peptidase activating factor 1
|
|
APBA3
|
amyloid beta (A4) precursor protein-binding, family A, member 3
|
|
APIP
|
APAF1 interacting protein
|
|
APLP2
|
amyloid beta (A4) precursor-like protein 2
|
|
APOA1
|
apolipoprotein A-I
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP1
|
aquaporin 1 (Colton blood group)
|
|
AR
|
androgen receptor
|
|
ARAF
|
A-Raf proto-oncogene, serine/threonine kinase
|
|
AREG
|
amphiregulin
|
|
ARF5
|
ADP-ribosylation factor 5
|
|
ARFGAP1
|
ADP-ribosylation factor GTPase activating protein 1
|
|
ARFGEF1
|
ADP-ribosylation factor guanine nucleotide-exchange factor 1 (brefeldin A-inhibited)
|
|
ARHGAP21
|
Rho GTPase activating protein 21
|
|
ARHGAP26
|
Rho GTPase activating protein 26
|
|
ARHGAP31
|
Rho GTPase activating protein 31
|
|
ARHGAP33
|
Rho GTPase activating protein 33
|
|
ARHGAP35
|
Rho GTPase activating protein 35
|
|
ARHGEF5
|
Rho guanine nucleotide exchange factor (GEF) 5
|
|
ARHGEF7
|
Rho guanine nucleotide exchange factor (GEF) 7
|
|
ARID1B
|
AT rich interactive domain 1B (SWI1-like)
|
|
ARIH2
|
ariadne RBR E3 ubiquitin protein ligase 2
|
|
ARRB1
|
arrestin, beta 1
|
|
ARRB2
|
arrestin, beta 2
|
|
ASCL1
|
achaete-scute family bHLH transcription factor 1
|
|
ATF1
|
activating transcription factor 1
|
|
ATF2
|
activating transcription factor 2
|
|
ATF3
|
activating transcription factor 3
|
|
ATF4
|
activating transcription factor 4
|
|
ATF5
|
activating transcription factor 5
|
|
ATF6
|
activating transcription factor 6
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATOH1
|
atonal homolog 1 (Drosophila)
|
|
ATR
|
ATR serine/threonine kinase
|
|
ATXN2
|
ataxin 2
|
|
AURKA
|
aurora kinase A
|
|
AVPR2
|
arginine vasopressin receptor 2
|
|
AXIN1
|
axin 1
|
|
B3GNT2
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2
|
|
B3GNT8
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8
|
|
BACE2
|
beta-site APP-cleaving enzyme 2
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BATF
|
basic leucine zipper transcription factor, ATF-like
|
|
BAX
|
BCL2-associated X protein
|
|
BBC3
|
BCL2 binding component 3
|
|
BCAR4
|
breast cancer anti-estrogen resistance 4 (non-protein coding)
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL3
|
B-cell CLL/lymphoma 3
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BECN1
|
beclin 1, autophagy related
|
|
BID
|
BH3 interacting domain death agonist
|
|
BIN1
|
bridging integrator 1
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BIRC7
|
baculoviral IAP repeat containing 7
|
|
BLVRA
|
biliverdin reductase A
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRSK1
|
BR serine/threonine kinase 1
|
|
BRSK2
|
BR serine/threonine kinase 2
|
|
BSG
|
basigin (Ok blood group)
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
|
C1QTNF6
|
C1q and tumor necrosis factor related protein 6
|
|
C3
|
complement component 3
|
|
CAB39
|
calcium binding protein 39
|
|
CACUL1
|
CDK2-associated, cullin domain 1
|
|
CALR
|
calreticulin
|
|
CAMK2A
|
calcium/calmodulin-dependent protein kinase II alpha
|
|
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CAPN1
|
calpain 1, (mu/I) large subunit
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CASP14
|
caspase 14, apoptosis-related cysteine peptidase
|
|
CASP2
|
caspase 2, apoptosis-related cysteine peptidase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP6
|
caspase 6, apoptosis-related cysteine peptidase
|
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CBR3
|
carbonyl reductase 3
|
|
CCAR1
|
cell division cycle and apoptosis regulator 1
|
|
CCKBR
|
cholecystokinin B receptor
|
|
CCL13
|
chemokine (C-C motif) ligand 13
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
|
CCL27
|
chemokine (C-C motif) ligand 27
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCL7
|
chemokine (C-C motif) ligand 7
|
|
CCNB1
|
cyclin B1
|
|
CCND1
|
cyclin D1
|
|
CCND3
|
cyclin D3
|
|
CCNE1
|
cyclin E1
|
|
CCNY
|
cyclin Y
|
|
CCR1
|
chemokine (C-C motif) receptor 1
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD19
|
CD19 molecule
|
|
CD226
|
CD226 molecule
|
|
CD244
|
CD244 molecule, natural killer cell receptor 2B4
|
|
CD247
|
CD247 molecule
|
|
CD28
|
CD28 molecule
|
|
CD300E
|
CD300e molecule
|
|
CD40LG
|
CD40 ligand
|
|
CD48
|
CD48 molecule
|
|
CD63
|
CD63 molecule
|
|
CD69
|
CD69 molecule
|
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
|
CD80
|
CD80 molecule
|
|
CDC25A
|
cell division cycle 25A
|
|
CDC25B
|
cell division cycle 25B
|
|
CDC25C
|
cell division cycle 25C
|
|
CDC42
|
cell division cycle 42
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK3
|
cyclin-dependent kinase 3
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK7
|
cyclin-dependent kinase 7
|
|
CDK8
|
cyclin-dependent kinase 8
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2AIP
|
CDKN2A interacting protein
|
|
CDX2
|
caudal type homeobox 2
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
|
CEACAM6
|
carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CERS6
|
ceramide synthase 6
|
|
CFH
|
complement factor H
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHGA
|
chromogranin A
|
|
CHRM3
|
cholinergic receptor, muscarinic 3
|
|
CHRNA6
|
cholinergic receptor, nicotinic, alpha 6 (neuronal)
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CIB1
|
calcium and integrin binding 1 (calmyrin)
|
|
CITED2
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
|
|
CLDN7
|
claudin 7
|
|
CLEC7A
|
C-type lectin domain family 7, member A
|
|
CLU
|
clusterin
|
|
CMA1
|
chymase 1, mast cell
|
|
CMKLR1
|
chemerin chemokine-like receptor 1
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
COL1A2
|
collagen, type I, alpha 2
|
|
COL2A1
|
collagen, type II, alpha 1
|
|
COMMD1
|
copper metabolism (Murr1) domain containing 1
|
|
COMT
|
catechol-O-methyltransferase
|
|
COX4I1
|
cytochrome c oxidase subunit IV isoform 1
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREBBP
|
CREB binding protein
|
|
CREM
|
cAMP responsive element modulator
|
|
CRH
|
corticotropin releasing hormone
|
|
CRLF2
|
cytokine receptor-like factor 2
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRTC1
|
CREB regulated transcription coactivator 1
|
|
CRTC2
|
CREB regulated transcription coactivator 2
|
|
CRTC3
|
CREB regulated transcription coactivator 3
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
|
CTGF
|
connective tissue growth factor
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNND2
|
catenin (cadherin-associated protein), delta 2
|
|
CTSB
|
cathepsin B
|
|
CTSG
|
cathepsin G
|
|
CTSL
|
cathepsin L
|
|
CTTN
|
cortactin
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYP11A1
|
cytochrome P450, family 11, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYR61
|
cysteine-rich, angiogenic inducer, 61
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DBI
|
diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein)
|
|
DCC
|
DCC netrin 1 receptor
|
|
DCLRE1C
|
DNA cross-link repair 1C
|
|
DCTN1
|
dynactin 1
|
|
DDAH1
|
dimethylarginine dimethylaminohydrolase 1
|
|
DDIT3
|
DNA-damage-inducible transcript 3
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DDX6
|
DEAD (Asp-Glu-Ala-Asp) box helicase 6
|
|
DGKE
|
diacylglycerol kinase, epsilon 64kDa
|
|
DIABLO
|
diablo, IAP-binding mitochondrial protein
|
|
DIO2
|
deiodinase, iodothyronine, type II
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DLL4
|
delta-like 4 (Drosophila)
|
|
DNM1
|
dynamin 1
|
|
DNMT3L
|
DNA (cytosine-5-)-methyltransferase 3-like
|
|
DUSP1
|
dual specificity phosphatase 1
|
|
DUSP4
|
dual specificity phosphatase 4
|
|
DUSP6
|
dual specificity phosphatase 6
|
|
E2F1
|
E2F transcription factor 1
|
|
E2F2
|
E2F transcription factor 2
|
|
E2F3
|
E2F transcription factor 3
|
|
ECT2
|
epithelial cell transforming 2
|
|
EDA2R
|
ectodysplasin A2 receptor
|
|
EDN1
|
endothelin 1
|
|
EDNRB
|
endothelin receptor type B
|
|
EFNB1
|
ephrin-B1
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGR1
|
early growth response 1
|
|
EGR2
|
early growth response 2
|
|
EIF1AX
|
eukaryotic translation initiation factor 1A, X-linked
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
EIF2AK3
|
eukaryotic translation initiation factor 2-alpha kinase 3
|
|
EIF2AK4
|
eukaryotic translation initiation factor 2 alpha kinase 4
|
|
EIF3I
|
eukaryotic translation initiation factor 3, subunit I
|
|
ELF4
|
E74-like factor 4 (ets domain transcription factor)
|
|
ELK1
|
ELK1, member of ETS oncogene family
|
|
EP300
|
E1A binding protein p300
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHA4
|
EPH receptor A4
|
|
EPHB1
|
EPH receptor B1
|
|
EPO
|
erythropoietin
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC6
|
excision repair cross-complementation group 6
|
|
ERF
|
Ets2 repressor factor
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ERN1
|
endoplasmic reticulum to nucleus signaling 1
|
|
ESR1
|
estrogen receptor 1
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
ETV1
|
ets variant 1
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
EZR
|
ezrin
|
|
F10
|
coagulation factor X
|
|
F11
|
coagulation factor XI
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F2RL3
|
coagulation factor II (thrombin) receptor-like 3
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
F9
|
coagulation factor IX
|
|
FAM162A
|
family with sequence similarity 162, member A
|
|
FBXO22
|
F-box protein 22
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FCER1G
|
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide
|
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23)
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
|
FCGR2C
|
Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene)
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FCMR
|
Fc fragment of IgM receptor
|
|
FCN3
|
ficolin (collagen/fibrinogen domain containing) 3
|
|
FCRL1
|
Fc receptor-like 1
|
|
FERMT3
|
fermitin family member 3
|
|
FGF1
|
fibroblast growth factor 1 (acidic)
|
|
FGF10
|
fibroblast growth factor 10
|
|
FGF19
|
fibroblast growth factor 19
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF21
|
fibroblast growth factor 21
|
|
FGF23
|
fibroblast growth factor 23
|
|
FGF7
|
fibroblast growth factor 7
|
|
FGFBP1
|
fibroblast growth factor binding protein 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FHIT
|
fragile histidine triad
|
|
FIGF
|
c-fos induced growth factor (vascular endothelial growth factor D)
|
|
FLOT1
|
flotillin 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FMR1
|
fragile X mental retardation 1
|
|
FN1
|
fibronectin 1
|
|
FNBP1L
|
formin binding protein 1-like
|
|
FOLR2
|
folate receptor 2 (fetal)
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOSL1
|
FOS-like antigen 1
|
|
FOXC1
|
forkhead box C1
|
|
FOXM1
|
forkhead box M1
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXO4
|
forkhead box O4
|
|
FPR1
|
formyl peptide receptor 1
|
|
FPR2
|
formyl peptide receptor 2
|
|
FPR3
|
formyl peptide receptor 3
|
|
FRMD6
|
FERM domain containing 6
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
FUT3
|
fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group)
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
FZR1
|
fizzy/cell division cycle 20 related 1 (Drosophila)
|
|
GABPA
|
GA binding protein transcription factor, alpha subunit 60kDa
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA2
|
GATA binding protein 2
|
|
GBF1
|
golgi brefeldin A resistant guanine nucleotide exchange factor 1
|
|
GCG
|
glucagon
|
|
GCK
|
glucokinase (hexokinase 4)
|
|
GCKR
|
glucokinase (hexokinase 4) regulator
|
|
GDF15
|
growth differentiation factor 15
|
|
GDI1
|
GDP dissociation inhibitor 1
|
|
GFRA1
|
GDNF family receptor alpha 1
|
|
GH1
|
growth hormone 1
|
|
GLI1
|
GLI family zinc finger 1
|
|
GLP2R
|
glucagon-like peptide 2 receptor
|
|
GLRA1
|
glycine receptor, alpha 1
|
|
GLUD1
|
glutamate dehydrogenase 1
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
|
GNAS
|
GNAS complex locus
|
|
GNB1
|
guanine nucleotide binding protein (G protein), beta polypeptide 1
|
|
GNB2L1
|
guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1
|
|
GNB3
|
guanine nucleotide binding protein (G protein), beta polypeptide 3
|
|
GNLY
|
granulysin
|
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)
|
|
GOLPH3
|
golgi phosphoprotein 3 (coat-protein)
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
|
GP6
|
glycoprotein VI (platelet)
|
|
GPR174
|
G protein-coupled receptor 174
|
|
GPT2
|
glutamic pyruvate transaminase (alanine aminotransferase) 2
|
|
GRB7
|
growth factor receptor-bound protein 7
|
|
GRIK2
|
glutamate receptor, ionotropic, kainate 2
|
|
GRM3
|
glutamate receptor, metabotropic 3
|
|
GSAP
|
gamma-secretase activating protein
|
|
GSK3A
|
glycogen synthase kinase 3 alpha
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSN
|
gelsolin
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GUCY2D
|
guanylate cyclase 2D, membrane (retina-specific)
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
H3F3A
|
H3 histone, family 3A
|
|
HABP2
|
hyaluronan binding protein 2
|
|
HAS2
|
hyaluronan synthase 2
|
|
HBB
|
hemoglobin, beta
|
|
HBEGF
|
heparin-binding EGF-like growth factor
|
|
HBG1
|
hemoglobin, gamma A
|
|
HCFC1
|
host cell factor C1
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC2
|
histone deacetylase 2
|
|
HDAC3
|
histone deacetylase 3
|
|
HES1
|
hes family bHLH transcription factor 1
|
|
HEY2
|
hes-related family bHLH transcription factor with YRPW motif 2
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIC1
|
hypermethylated in cancer 1
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIPK2
|
homeodomain interacting protein kinase 2
|
|
HK2
|
hexokinase 2
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HMGB1
|
high mobility group box 1
|
|
HMOX1
|
heme oxygenase 1
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HNRNPA1
|
heterogeneous nuclear ribonucleoprotein A1
|
|
HNRNPD
|
heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa)
|
|
HNRNPK
|
heterogeneous nuclear ribonucleoprotein K
|
|
HOXA10
|
homeobox A10
|
|
HOXC9
|
homeobox C9
|
|
HPSE
|
heparanase
|
|
HPSE2
|
heparanase 2 (inactive)
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HRH1
|
histamine receptor H1
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPA9
|
heat shock 70kDa protein 9 (mortalin)
|
|
HTT
|
huntingtin
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IFNL1
|
interferon, lambda 1
|
|
IFNL2
|
interferon, lambda 2
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGFBP4
|
insulin-like growth factor binding protein 4
|
|
IGFBP5
|
insulin-like growth factor binding protein 5
|
|
IGK
|
immunoglobulin kappa locus
|
|
IHH
|
indian hedgehog
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
IL10
|
interleukin 10
|
|
IL12A
|
interleukin 12A
|
|
IL13
|
interleukin 13
|
|
IL15
|
interleukin 15
|
|
IL17A
|
interleukin 17A
|
|
IL17F
|
interleukin 17F
|
|
IL18
|
interleukin 18
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL21
|
interleukin 21
|
|
IL22
|
interleukin 22
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL24
|
interleukin 24
|
|
IL25
|
interleukin 25
|
|
IL27
|
interleukin 27
|
|
IL33
|
interleukin 33
|
|
IL33R
|
interleukin 33 receptor
|
|
IL4
|
interleukin 4
|
|
IL6
|
interleukin 6
|
|
IL7
|
interleukin 7
|
|
IL7R
|
interleukin 7 receptor
|
|
IL9
|
interleukin 9
|
|
ILK
|
integrin-linked kinase
|
|
INF2
|
inverted formin, FH2 and WH2 domain containing
|
|
ING1
|
inhibitor of growth family, member 1
|
|
INHBA
|
inhibin, beta A
|
|
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa
|
|
INS
|
insulin
|
|
IQGAP1
|
IQ motif containing GTPase activating protein 1
|
|
IQSEC1
|
IQ motif and Sec7 domain 1
|
|
IRF3
|
interferon regulatory factor 3
|
|
IRX2
|
iroquois homeobox 2
|
|
ITGA3
|
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB5
|
integrin, beta 5
|
|
ITGB6
|
integrin, beta 6
|
|
ITGB8
|
integrin, beta 8
|
|
ITPR1
|
inositol 1,4,5-trisphosphate receptor, type 1
|
|
IVL
|
involucrin
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
JAK3
|
Janus kinase 3
|
|
JUN
|
jun proto-oncogene
|
|
KAT2B
|
K(lysine) acetyltransferase 2B
|
|
KAT6A
|
K(lysine) acetyltransferase 6A
|
|
KAT6B
|
K(lysine) acetyltransferase 6B
|
|
KCNB1
|
potassium channel, voltage gated Shab related subfamily B, member 1
|
|
KCNE1
|
potassium channel, voltage gated subfamily E regulatory beta subunit 1
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
|
KCNJ8
|
potassium channel, inwardly rectifying subfamily J, member 8
|
|
KCNMB1
|
potassium channel subfamily M regulatory beta subunit 1
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KCTD10
|
potassium channel tetramerization domain containing 10
|
|
KDM4C
|
lysine (K)-specific demethylase 4C
|
|
KDR
|
kinase insert domain receptor
|
|
KEAP1
|
kelch-like ECH-associated protein 1
|
|
KIF1B
|
kinesin family member 1B
|
|
KIF23
|
kinesin family member 23
|
|
KIR2DL1
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1
|
|
KIR2DL2
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2
|
|
KIR2DL3
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3
|
|
KIR2DL4
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4
|
|
KIR2DS1
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1
|
|
KIR2DS2
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2
|
|
KIR2DS3
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 3
|
|
KIR2DS4
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4
|
|
KIR2DS5
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5
|
|
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
|
|
KIR3DL3
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3
|
|
KIR3DS1
|
killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KITLG
|
KIT ligand
|
|
KLF1
|
Kruppel-like factor 1 (erythroid)
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLF5
|
Kruppel-like factor 5 (intestinal)
|
|
KLF8
|
Kruppel-like factor 8
|
|
KLK4
|
kallikrein-related peptidase 4
|
|
KLK7
|
kallikrein-related peptidase 7
|
|
KLRC1
|
killer cell lectin-like receptor subfamily C, member 1
|
|
KLRC2
|
killer cell lectin-like receptor subfamily C, member 2
|
|
KLRD1
|
killer cell lectin-like receptor subfamily D, member 1
|
|
KLRF1
|
killer cell lectin-like receptor subfamily F, member 1
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KMT2D
|
lysine (K)-specific methyltransferase 2D
|
|
KNG1
|
kininogen 1
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KSR1
|
kinase suppressor of ras 1
|
|
L1CAM
|
L1 cell adhesion molecule
|
|
LAMTOR5
|
late endosomal/lysosomal adaptor, MAPK and MTOR activator 5
|
|
LAT
|
linker for activation of T cells
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LCP2
|
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
|
LEP
|
leptin
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LGALS9
|
lectin, galactoside-binding, soluble, 9
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LIG4
|
ligase IV, DNA, ATP-dependent
|
|
LILRA2
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2
|
|
LILRA6
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6
|
|
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
|
|
LIMS1
|
LIM and senescent cell antigen-like domains 1
|
|
LIN28B
|
lin-28 homolog B (C. elegans)
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
LRRC3DN
|
LRRC3 downstream neighbor (non-protein coding)
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LTC4S
|
leukotriene C4 synthase
|
|
LUM
|
lumican
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MAB21L1
|
mab-21-like 1 (C. elegans)
|
|
MAGEL2
|
melanoma antigen family L2
|
|
MALT1
|
MALT1 paracaspase
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K3
|
mitogen-activated protein kinase kinase 3
|
|
MAP2K6
|
mitogen-activated protein kinase kinase 6
|
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase
|
|
MAP3K14
|
mitogen-activated protein kinase kinase kinase 14
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAP3K7
|
mitogen-activated protein kinase kinase kinase 7
|
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8
|
|
MAP3K9
|
mitogen-activated protein kinase kinase kinase 9
|
|
MAP4K3
|
mitogen-activated protein kinase kinase kinase kinase 3
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK12
|
mitogen-activated protein kinase 12
|
|
MAPK13
|
mitogen-activated protein kinase 13
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2
|
|
MAPRE2
|
microtubule-associated protein, RP/EB family, member 2
|
|
MARCH5
|
membrane-associated ring finger (C3HC4) 5
|
|
MASP1
|
mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor)
|
|
MASP2
|
mannan-binding lectin serine peptidase 2
|
|
MAX
|
MYC associated factor X
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MED12
|
mediator complex subunit 12
|
|
MEFV
|
Mediterranean fever
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFN2
|
mitofusin 2
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MICB
|
MHC class I polypeptide-related sequence B
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR106B
|
microRNA 106b
|
|
MIR122
|
microRNA 122
|
|
MIR124-1
|
microRNA 124-1
|
|
MIR148A
|
microRNA 148a
|
|
MIR155
|
microRNA 155
|
|
MIR182
|
microRNA 182
|
|
MIR200C
|
microRNA 200c
|
|
MIR208A
|
microRNA 208a
|
|
MIR20A
|
microRNA 20a
|
|
MIR21
|
microRNA 21
|
|
MIR221
|
microRNA 221
|
|
MIR222
|
microRNA 222
|
|
MIR223
|
microRNA 223
|
|
MIR25
|
microRNA 25
|
|
MIR27A
|
microRNA 27a
|
|
MIR301A
|
microRNA 301a
|
|
MIR30A
|
microRNA 30a
|
|
MIR31
|
microRNA 31
|
|
MIR330
|
microRNA 330
|
|
MIR371A
|
microRNA 371a
|
|
MIR449A
|
microRNA 449a
|
|
MIR451A
|
microRNA 451a
|
|
MIR494
|
microRNA 494
|
|
MIR499A
|
microRNA 499a
|
|
MIRLET7A1
|
microRNA let-7a-1
|
|
MKNK1
|
MAP kinase interacting serine/threonine kinase 1
|
|
MMP10
|
matrix metallopeptidase 10
|
|
MMP12
|
matrix metallopeptidase 12
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
MRC1
|
mannose receptor, C type 1
|
|
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MVP
|
major vault protein
|
|
MYBPH
|
myosin binding protein H
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYO9B
|
myosin IXB
|
|
MYOCD
|
myocardin
|
|
NAT1
|
N-acetyltransferase 1 (arylamine N-acetyltransferase)
|
|
NAV1
|
neuron navigator 1
|
|
NCR1
|
natural cytotoxicity triggering receptor 1
|
|
NCR2
|
natural cytotoxicity triggering receptor 2
|
|
NCR3
|
natural cytotoxicity triggering receptor 3
|
|
NCR3LG1
|
natural killer cell cytotoxicity receptor 3 ligand 1
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NET1
|
neuroepithelial cell transforming 1
|
|
NFAT5
|
nuclear factor of activated T-cells 5, tonicity-responsive
|
|
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFE4
|
nuclear factor, erythroid 4
|
|
NFIA
|
nuclear factor I/A
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NKX2-5
|
NK2 homeobox 5
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NMNAT1
|
nicotinamide nucleotide adenylyltransferase 1
|
|
NNMT
|
nicotinamide N-methyltransferase
|
|
NOD1
|
nucleotide-binding oligomerization domain containing 1
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH2
|
notch 2
|
|
NOTCH3
|
notch 3
|
|
NOX1
|
NADPH oxidase 1
|
|
NOX5
|
NADPH oxidase, EF-hand calcium binding domain 5
|
|
NPC1
|
Niemann-Pick disease, type C1
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPY
|
neuropeptide Y
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR1H2
|
nuclear receptor subfamily 1, group H, member 2
|
|
NR1H3
|
nuclear receptor subfamily 1, group H, member 3
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR1I3
|
nuclear receptor subfamily 1, group I, member 3
|
|
NR2C1
|
nuclear receptor subfamily 2, group C, member 1
|
|
NR2C2AP
|
nuclear receptor 2C2-associated protein
|
|
NR2F2
|
nuclear receptor subfamily 2, group F, member 2
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRG1
|
neuregulin 1
|
|
NTF3
|
neurotrophin 3
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NUP88
|
nucleoporin 88kDa
|
|
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa
|
|
OLIG2
|
oligodendrocyte lineage transcription factor 2
|
|
OPRD1
|
opioid receptor, delta 1
|
|
OPRK1
|
opioid receptor, kappa 1
|
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1
|
|
ORMDL3
|
ORMDL sphingolipid biosynthesis regulator 3
|
|
OXT
|
oxytocin/neurophysin I prepropeptide
|
|
P2RY1
|
purinergic receptor P2Y, G-protein coupled, 1
|
|
PAFAH1B1
|
platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa)
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PAK7
|
p21 protein (Cdc42/Rac)-activated kinase 7
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARK7
|
parkinson protein 7
|
|
PATZ1
|
POZ (BTB) and AT hook containing zinc finger 1
|
|
PAWR
|
PRKC, apoptosis, WT1, regulator
|
|
PAX2
|
paired box 2
|
|
PAX5
|
paired box 5
|
|
PCDH9
|
protocadherin 9
|
|
PDCD10
|
programmed cell death 10
|
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
|
PDCD5
|
programmed cell death 5
|
|
PDCD6
|
programmed cell death 6
|
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDPK1
|
3-phosphoinositide dependent protein kinase 1
|
|
PDX1
|
pancreatic and duodenal homeobox 1
|
|
PFKM
|
phosphofructokinase, muscle
|
|
PGR
|
progesterone receptor
|
|
PI4KA
|
phosphatidylinositol 4-kinase, catalytic, alpha
|
|
PID1
|
phosphotyrosine interaction domain containing 1
|
|
PIDD1
|
p53-induced death domain protein 1
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIKFYVE
|
phosphoinositide kinase, FYVE finger containing
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PIP5K1A
|
phosphatidylinositol-4-phosphate 5-kinase, type I, alpha
|
|
PITX1
|
paired-like homeodomain 1
|
|
PITX2
|
paired-like homeodomain 2
|
|
PKLR
|
pyruvate kinase, liver and RBC
|
|
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid)
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PLD1
|
phospholipase D1, phosphatidylcholine-specific
|
|
PLD2
|
phospholipase D2
|
|
PLK1
|
polo-like kinase 1
|
|
PLXNB1
|
plexin B1
|
|
PLXND1
|
plexin D1
|
|
PNKD
|
paroxysmal nonkinesigenic dyskinesia
|
|
PNPLA2
|
patatin-like phospholipase domain containing 2
|
|
POSTN
|
periostin, osteoblast specific factor
|
|
POU2F2
|
POU class 2 homeobox 2
|
|
POU4F3
|
POU class 4 homeobox 3
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPARGC1B
|
peroxisome proliferator-activated receptor gamma, coactivator 1 beta
|
|
PPP1R15A
|
protein phosphatase 1, regulatory subunit 15A
|
|
PPP1R2
|
protein phosphatase 1, regulatory (inhibitor) subunit 2
|
|
PPP2R4
|
protein phosphatase 2A activator, regulatory subunit 4
|
|
PPP2R5C
|
protein phosphatase 2, regulatory subunit B', gamma
|
|
PPT1
|
palmitoyl-protein thioesterase 1
|
|
PRDX1
|
peroxiredoxin 1
|
|
PRDX2
|
peroxiredoxin 2
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PRKCI
|
protein kinase C, iota
|
|
PRKCQ
|
protein kinase C, theta
|
|
PRKD3
|
protein kinase D3
|
|
PRKG1
|
protein kinase, cGMP-dependent, type I
|
|
PRMT5
|
protein arginine methyltransferase 5
|
|
PRNP
|
prion protein
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PROCR
|
protein C receptor, endothelial
|
|
PRODH
|
proline dehydrogenase (oxidase) 1
|
|
PROM1
|
prominin 1
|
|
PRPF4B
|
pre-mRNA processing factor 4B
|
|
PRSS3
|
protease, serine, 3
|
|
PRSS8
|
protease, serine, 8
|
|
PRTN3
|
proteinase 3
|
|
PSAP
|
prosaposin
|
|
PSMD10
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 10
|
|
PSTPIP2
|
proline-serine-threonine phosphatase interacting protein 2
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGER1
|
prostaglandin E receptor 1 (subtype EP1), 42kDa
|
|
PTGER2
|
prostaglandin E receptor 2 (subtype EP2), 53kDa
|
|
PTGFR
|
prostaglandin F receptor (FP)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTH1R
|
parathyroid hormone 1 receptor
|
|
PTHLH
|
parathyroid hormone-like hormone
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK6
|
protein tyrosine kinase 6
|
|
PTMA
|
prothymosin, alpha
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN2
|
protein tyrosine phosphatase, non-receptor type 2
|
|
PTPN3
|
protein tyrosine phosphatase, non-receptor type 3
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
PTPRU
|
protein tyrosine phosphatase, receptor type, U
|
|
PVR
|
poliovirus receptor
|
|
PVRL2
|
poliovirus receptor-related 2 (herpesvirus entry mediator B)
|
|
PXN
|
paxillin
|
|
PYCARD
|
PYD and CARD domain containing
|
|
RAB38
|
RAB38, member RAS oncogene family
|
|
RAB4A
|
RAB4A, member RAS oncogene family
|
|
RAB5A
|
RAB5A, member RAS oncogene family
|
|
RAB7B
|
RAB7B, member RAS oncogene family
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)
|
|
RACGAP1
|
Rac GTPase activating protein 1
|
|
RAD51
|
RAD51 recombinase
|
|
RAET1E
|
retinoic acid early transcript 1E
|
|
RAET1G
|
retinoic acid early transcript 1G
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RAG1
|
recombination activating gene 1
|
|
RAG2
|
recombination activating gene 2
|
|
RALBP1
|
ralA binding protein 1
|
|
RAP1A
|
RAP1A, member of RAS oncogene family
|
|
RARRES2
|
retinoic acid receptor responder (tazarotene induced) 2
|
|
RASA1
|
RAS p21 protein activator (GTPase activating protein) 1
|
|
RASAL1
|
RAS protein activator like 1 (GAP1 like)
|
|
RD3
|
retinal degeneration 3
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RELB
|
v-rel avian reticuloendotheliosis viral oncogene homolog B
|
|
RELN
|
reelin
|
|
RET
|
ret proto-oncogene
|
|
RETN
|
resistin
|
|
RFXAP
|
regulatory factor X-associated protein
|
|
RGS14
|
regulator of G-protein signaling 14
|
|
RGS16
|
regulator of G-protein signaling 16
|
|
RGS4
|
regulator of G-protein signaling 4
|
|
RHBDD1
|
rhomboid domain containing 1
|
|
RHEB
|
Ras homolog enriched in brain
|
|
RHO
|
rhodopsin
|
|
RHOA
|
ras homolog family member A
|
|
RHOB
|
ras homolog family member B
|
|
RHOJ
|
ras homolog family member J
|
|
RICTOR
|
RPTOR independent companion of MTOR, complex 2
|
|
RIPK1
|
receptor (TNFRSF)-interacting serine-threonine kinase 1
|
|
RIPK2
|
receptor-interacting serine-threonine kinase 2
|
|
RIT1
|
Ras-like without CAAX 1
|
|
RNF20
|
ring finger protein 20, E3 ubiquitin protein ligase
|
|
ROBO4
|
roundabout, axon guidance receptor, homolog 4 (Drosophila)
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
RPN2
|
ribophorin II
|
|
RPS3
|
ribosomal protein S3
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
RPS6KA3
|
ribosomal protein S6 kinase, 90kDa, polypeptide 3
|
|
RPS6KA5
|
ribosomal protein S6 kinase, 90kDa, polypeptide 5
|
|
RPSA
|
ribosomal protein SA
|
|
RRAS
|
related RAS viral (r-ras) oncogene homolog
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
RUNX3
|
runt-related transcription factor 3
|
|
RWDD2B
|
RWD domain containing 2B
|
|
RXFP2
|
relaxin/insulin-like family peptide receptor 2
|
|
RXRA
|
retinoid X receptor, alpha
|
|
RYR2
|
ryanodine receptor 2 (cardiac)
|
|
RYR3
|
ryanodine receptor 3
|
|
S100A11
|
S100 calcium binding protein A11
|
|
S100A4
|
S100 calcium binding protein A4
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100A9
|
S100 calcium binding protein A9
|
|
S100B
|
S100 calcium binding protein B
|
|
S1PR1
|
sphingosine-1-phosphate receptor 1
|
|
SAA1
|
serum amyloid A1
|
|
SAE1
|
SUMO1 activating enzyme subunit 1
|
|
SAT1
|
spermidine/spermine N1-acetyltransferase 1
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SDC1
|
syndecan 1
|
|
SELE
|
selectin E
|
|
SELPLG
|
selectin P ligand
|
|
SEMA3E
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E
|
|
SEMA5A
|
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A
|
|
SEPT9
|
septin 9
|
|
SERPINB4
|
serpin peptidase inhibitor, clade B (ovalbumin), member 4
|
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
|
|
SF1
|
splicing factor 1
|
|
SFTPA1
|
surfactant protein A1
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SGK2
|
serum/glucocorticoid regulated kinase 2
|
|
SGK3
|
serum/glucocorticoid regulated kinase family, member 3
|
|
SH2B1
|
SH2B adaptor protein 1
|
|
SH2D1A
|
SH2 domain containing 1A
|
|
SH3GL2
|
SH3-domain GRB2-like 2
|
|
SHANK2
|
SH3 and multiple ankyrin repeat domains 2
|
|
SHH
|
sonic hedgehog
|
|
SIN3A
|
SIN3 transcription regulator family member A
|
|
SIRT1
|
sirtuin 1
|
|
SIRT4
|
sirtuin 4
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLAMF6
|
SLAM family member 6
|
|
SLC19A1
|
solute carrier family 19 (folate transporter), member 1
|
|
SLC33A1
|
solute carrier family 33 (acetyl-CoA transporter), member 1
|
|
SLC7A11
|
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11
|
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
|
|
SLC9A3
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3
|
|
SLIT2
|
slit homolog 2 (Drosophila)
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD4
|
SMAD family member 4
|
|
SMAD7
|
SMAD family member 7
|
|
SMARCD3
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3
|
|
SMO
|
smoothened, frizzled class receptor
|
|
SMPD1
|
sphingomyelin phosphodiesterase 1, acid lysosomal
|
|
SMPD2
|
sphingomyelin phosphodiesterase 2, neutral membrane (neutral sphingomyelinase)
|
|
SMTNL1
|
smoothelin-like 1
|
|
SMYD3
|
SET and MYND domain containing 3
|
|
SNAI1
|
snail family zinc finger 1
|
|
SNAI2
|
snail family zinc finger 2
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOX11
|
SRY (sex determining region Y)-box 11
|
|
SP1
|
Sp1 transcription factor
|
|
SP110
|
SP110 nuclear body protein
|
|
SP3
|
Sp3 transcription factor
|
|
SPINK5
|
serine peptidase inhibitor, Kazal type 5
|
|
SPN
|
sialophorin
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPTAN1
|
spectrin, alpha, non-erythrocytic 1
|
|
SQSTM1
|
sequestosome 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRR
|
serine racemase
|
|
SRSF1
|
serine/arginine-rich splicing factor 1
|
|
SSH1
|
slingshot protein phosphatase 1
|
|
SST
|
somatostatin
|
|
SSTR2
|
somatostatin receptor 2
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STIM1
|
stromal interaction molecule 1
|
|
STIM2
|
stromal interaction molecule 2
|
|
STK11
|
serine/threonine kinase 11
|
|
STK25
|
serine/threonine kinase 25
|
|
STK4
|
serine/threonine kinase 4
|
|
STRADA
|
STE20-related kinase adaptor alpha
|
|
STUB1
|
STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase
|
|
STX2
|
syntaxin 2
|
|
SUMO1
|
small ubiquitin-like modifier 1
|
|
SYK
|
spleen tyrosine kinase
|
|
TAB1
|
TGF-beta activated kinase 1/MAP3K7 binding protein 1
|
|
TAC1
|
tachykinin, precursor 1
|
|
TACR3
|
tachykinin receptor 3
|
|
TAF1
|
TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa
|
|
TAL1
|
T-cell acute lymphocytic leukemia 1
|
|
TAT
|
tyrosine aminotransferase
|
|
TBC1D16
|
TBC1 domain family, member 16
|
|
TBL1XR1
|
transducin (beta)-like 1 X-linked receptor 1
|
|
TBX2
|
T-box 2
|
|
TBXA2R
|
thromboxane A2 receptor
|
|
TCERG1
|
transcription elongation regulator 1
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TERT
|
telomerase reverse transcriptase
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
|
TFAP2B
|
transcription factor AP-2 beta (activating enhancer binding protein 2 beta)
|
|
TFAP2D
|
transcription factor AP-2 delta (activating enhancer binding protein 2 delta)
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TFRC
|
transferrin receptor
|
|
TGFA
|
transforming growth factor, alpha
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB3
|
transforming growth factor, beta 3
|
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGFBR3
|
transforming growth factor, beta receptor III
|
|
TGM2
|
transglutaminase 2
|
|
THBD
|
thrombomodulin
|
|
THBS1
|
thrombospondin 1
|
|
THOC1
|
THO complex 1
|
|
TIE1
|
tyrosine kinase with immunoglobulin-like and EGF-like domains 1
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TLR1
|
toll-like receptor 1
|
|
TLR2
|
toll-like receptor 2
|
|
TLR4
|
toll-like receptor 4
|
|
TLR9
|
toll-like receptor 9
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
|
TMPRSS4
|
transmembrane protease, serine 4
|
|
TMSB10
|
thymosin beta 10
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP1
|
tumor necrosis factor, alpha-induced protein 1 (endothelial)
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF12A
|
tumor necrosis factor receptor superfamily, member 12A
|
|
TNFRSF13B
|
tumor necrosis factor receptor superfamily, member 13B
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF6B
|
tumor necrosis factor receptor superfamily, member 6b, decoy
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF12
|
tumor necrosis factor (ligand) superfamily, member 12
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TNFSF14
|
tumor necrosis factor (ligand) superfamily, member 14
|
|
TNFSF9
|
tumor necrosis factor (ligand) superfamily, member 9
|
|
TNIP2
|
TNFAIP3 interacting protein 2
|
|
TNK2
|
tyrosine kinase, non-receptor, 2
|
|
TNKS
|
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase
|
|
TOB1
|
transducer of ERBB2, 1
|
|
TOPBP1
|
topoisomerase (DNA) II binding protein 1
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPI1
|
triosephosphate isomerase 1
|
|
TPSG1
|
tryptase gamma 1
|
|
TRADD
|
TNFRSF1A-associated via death domain
|
|
TRAF3IP2
|
TRAF3 interacting protein 2
|
|
TRAPPC4
|
trafficking protein particle complex 4
|
|
TREM1
|
triggering receptor expressed on myeloid cells 1
|
|
TREM2
|
triggering receptor expressed on myeloid cells 2
|
|
TREML3P
|
triggering receptor expressed on myeloid cells-like 3, pseudogene
|
|
TRIM27
|
tripartite motif containing 27
|
|
TRIO
|
trio Rho guanine nucleotide exchange factor
|
|
TRIP12
|
thyroid hormone receptor interactor 12
|
|
TRPA1
|
transient receptor potential cation channel, subfamily A, member 1
|
|
TRPC3
|
transient receptor potential cation channel, subfamily C, member 3
|
|
TRPC6
|
transient receptor potential cation channel, subfamily C, member 6
|
|
TRPM7
|
transient receptor potential cation channel, subfamily M, member 7
|
|
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TSC2
|
tuberous sclerosis 2
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
TWIST2
|
twist family bHLH transcription factor 2
|
|
TXN
|
thioredoxin
|
|
TXNIP
|
thioredoxin interacting protein
|
|
TYROBP
|
TYRO protein tyrosine kinase binding protein
|
|
UBA2
|
ubiquitin-like modifier activating enzyme 2
|
|
UBA6
|
ubiquitin-like modifier activating enzyme 6
|
|
UBE2M
|
ubiquitin-conjugating enzyme E2M
|
|
UBE3A
|
ubiquitin protein ligase E3A
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier)
|
|
ULK1
|
unc-51 like autophagy activating kinase 1
|
|
USP25
|
ubiquitin specific peptidase 25
|
|
UVRAG
|
UV radiation resistance associated
|
|
VAC14
|
Vac14 homolog (S. cerevisiae)
|
|
VAV1
|
vav 1 guanine nucleotide exchange factor
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VCL
|
vinculin
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VIM
|
vimentin
|
|
VIP
|
vasoactive intestinal peptide
|
|
WAS
|
Wiskott-Aldrich syndrome
|
|
WASL
|
Wiskott-Aldrich syndrome-like
|
|
WDR35
|
WD repeat domain 35
|
|
WDR5
|
WD repeat domain 5
|
|
WLS
|
wntless Wnt ligand secretion mediator
|
|
WNT1
|
wingless-type MMTV integration site family, member 1
|
|
WNT10A
|
wingless-type MMTV integration site family, member 10A
|
|
WNT2
|
wingless-type MMTV integration site family member 2
|
|
WNT3A
|
wingless-type MMTV integration site family, member 3A
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
XBP1
|
X-box binding protein 1
|
|
YAP1
|
Yes-associated protein 1
|
|
YWHAQ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
|
ZEB2
|
zinc finger E-box binding homeobox 2
|
|
ZKSCAN4
|
zinc finger with KRAB and SCAN domains 4
|
|
ZNF148
|
zinc finger protein 148
|
